Autres langues SyntheticMR AB

Actions

SYNT

SE0015987946

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 00:00:00 31/01/2024			Varia. 5j.	Varia. 1 janv.
27,7 ^SEK	+1,09%		-.--%	+4,14%

17/04	SyntheticMR AB et SimonMed Imaging étendent les essais d'IRM synthétique et annoncent l'extension prochaine de la disponibilité du logiciel synthétique dans les installations de SimonMed	CI
27/03	SyntheticMR reçoit l'autorisation 510(k) de la FDA pour sa solution de nouvelle génération SyMRI 3D	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Notice to attend the annual general meeting of SyntheticMR AB (publ)	19/04
SyntheticMR publishes annual report for 2023	19/04
SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities.	17/04
SyntheticMR AB and SimonMed Imaging Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from Synthetic Software at SimonMed Facilities	17/04
SyntheticMR : and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities	17/04
SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D	27/03
SyntheticMR Receives FDA 510(k) Clearance for Their Next Generation Solution SyMRI 3D	27/03
Decided allocation regarding incentive program LTIP 2024 and TO 2	12/03
Fixed subscription price for warrants of series TO 2 and TO 3	05/03
Philips teams with Synthetic MR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients at ECR2024	01/03
Royal Philips Partners SyntheticMR to Roll Out New Brain Disorder Diagnosis Technology	01/03
Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients	01/03
Subscription price for shares in the incentive program LTIP 2024	27/02
Report from the extraordinary general meeting in SyntheticMR AB (publ)	20/02
Year-End report January - December 2023	20/02
SyntheticMR AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/02
SyntheticMR AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Notice to attend the extraordinary general meeting of SyntheticMR AB (publ)	19/01
SyntheticMR AB intends to introduce incentive programs for the company's staff	18/01
SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking	18/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SyntheticMR AB

Actions

SYNT

SE0015987946

Autres langues

Filtres